ArticleJournal of market access & health policy2024

INEAS's Cost-Effectiveness Analysis of Vemurafenib: Paving the Way for Value-Based Pricing in Tunisia.

Mouna Jameleddine et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.